Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group
Philippe Moreau, Shaji Kumar, Jesús F. San Miguel, Faith E. Davies, Elena Zamagni, Nizar J. Bahlis, Heinz Ludwig, Joseph Mıkhael, Evangelos Terpos, Fredrik Schjesvold, Thomas G. Martin, Kwee Yong, Brian G.M. Durie, Thierry Façon, Artur Jurczyszyn, Surbhi Sidana, Noopur Raje, Niels W.C.J. van de Donk, Sagar Lonial, Michèle Cavo, Sigurður Y. Kristinsson, Suzanne Lentzsch, Roman Hájek, Kenneth C. Anderson, Cristina João, Hermann Einsele, Pieter Sonneveld, Monika Engelhardt, Rafaël Fonseca, Annette Juul Vangsted, Katja Weisel, Rachid Baz, Vânia Hungria, Jesús G. Berdeja, Fernando Leal da Costa, Ângelo Maiolino, Anders Waage, David H. Vesole, Enrique M. Ocio, Hang Quach, Christoph Driessen, Joan Bladé, Xavier Leleu, Eloísa Riva, P. Leif Bergsagel, Jian Hou, Wee Joo Chng, Ulf-Henrik Mellqvist, Dominik Dytfeld, Jean‐Luc Harousseau, Hartmut Goldschmidt, Jacob P. Laubach, Nikhil C. Munshi, Francesca Gay, Meral Beksaç, Luciano J. Costa, Martin Kaiser, Parameswaran Hari, Mario Boccadoro, Saad Z. Usmani, Sonja Zweegman, Sarah A. Holstein, Orhan Sezer, Simon J. Harrison, Hareth Nahi, Gordon Cook, María‐Victoria Mateos, S. Vincent Rajkumar, Meletios A Dimopoulos, Paul G. Richardson (2021). Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group. , 22(3), DOI: https://doi.org/10.1016/s1470-2045(20)30756-7.
Article36 days agoTreatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group
Philippe Moreau, Shaji Kumar, Jesús F. San Miguel, Faith E. Davies, Elena Zamagni, Nizar J. Bahlis, Heinz Ludwig, Joseph Mıkhael, Evangelos Terpos, Fredrik Schjesvold, Thomas G. Martin, Kwee Yong, Brian G.M. Durie, Thierry Façon, Artur Jurczyszyn, Surbhi Sidana, Noopur Raje, Niels W.C.J. van de Donk, Sagar Lonial, Michèle Cavo, Sigurður Y. Kristinsson, Suzanne Lentzsch, Roman Hájek, Kenneth C. Anderson, Cristina João, Hermann Einsele, Pieter Sonneveld, Monika Engelhardt, Rafaël Fonseca, Annette Juul Vangsted, Katja Weisel, Rachid Baz, Vânia Hungria, Jesús G. Berdeja, Fernando Leal da Costa, Ângelo Maiolino, Anders Waage, David H. Vesole, Enrique M. Ocio, Hang Quach, Christoph Driessen, Joan Bladé, Xavier Leleu, Eloísa Riva, P. Leif Bergsagel, Jian Hou, Wee Joo Chng, Ulf‐Henrik Mellqvist, Dominik Dytfeld, Jean‐Luc Harousseau, Hartmut Goldschmidt, Jacob P. Laubach, Nikhil C. Munshi, Meral Beksaç, Luciano J. Costa, Martin Kaiser, Parameswaran Hari, Mario Boccadoro, Saad Z. Usmani, Sonja Zweegman, Sarah A. Holstein, Orhan Sezer, Simon J. Harrison, Hareth Nahi, Gordon Cook, María‐Victoria Mateos, S. Vincent Rajkumar, Meletios A Dimopoulos, Paul G. Richardson (2021). Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group.
Article36 days agoP-204: Carfilzomib, Dexamethasone, and Daratumumab (KdD) vs Kd: subgroup analysis of the CANDOR study by prior autologous stem cell transplantation, Lenalidomide exposure, or Lenalidomide refractory disease
María‐Victoria Mateos, Saad Z. Usmani, Hang Quach, Meletios A Dimopoulos, Rafaël Fonseca, Ian McFadden, Akeem Yusuf, Monica Khurana, Mihaela Obreja, Andrew Spencer (2021). P-204: Carfilzomib, Dexamethasone, and Daratumumab (KdD) vs Kd: subgroup analysis of the CANDOR study by prior autologous stem cell transplantation, Lenalidomide exposure, or Lenalidomide refractory disease. , 21, DOI: https://doi.org/10.1016/s2152-2650(21)02331-4.
Article36 days agoEfficacy and Safety of Carfilzomib, Lenalidomide, and Dexamethasone Vs Lenalidomide and Dexamethasone in Patients with Relapsed Multiple Myeloma Based on Cytogenetic Risk Status: Subgroup Analysis from the Phase 3 Study Aspire (NCT01080391)
Hervé Avet‐Loiseau, Rafaël Fonseca, David S. Siegel, Meletios A Dimopoulos, Ivan Špıčka, Tamás Masszi, Roman Hájek, Laura Rosiñol, Vesselina Goranova‐Marinova, Georgi Mihaylov, Vladimír Maisnar, María-Victoria Mateos, Michael Wang, Rubén Niesvizky, Albert Oriol, Andrzej Jakubowiak, Jiří Minařík, Antonio Palumbo, William Bensinger, Vishal Kukreti, Dina Ben‐Yehuda, Margaret Tonda, Mihaela Obreja, Philippe Moreau (2015). Efficacy and Safety of Carfilzomib, Lenalidomide, and Dexamethasone Vs Lenalidomide and Dexamethasone in Patients with Relapsed Multiple Myeloma Based on Cytogenetic Risk Status: Subgroup Analysis from the Phase 3 Study Aspire (NCT01080391). , 126(23), DOI: https://doi.org/10.1182/blood.v126.23.731.731.
Article36 days agoPlasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group
Carlos Fernández de Larrea, Robert A. Kyle, Brian G.M. Durie, Heinz Ludwig, Saad Z. Usmani, David H. Vesole, Roman Hájek, Jesús F. San Miguel, Orhan Sezer, Pieter Sonneveld, Shaji Kumar, Anuj Mahindra, Raymond L. Comenzo, Antonio Palumbo, A Mazumber, Kenneth C. Anderson, Paul G. Richardson, Ashraf Badros, Jo Caers, Michèle Cavo, Xavier Leleu, Meletios A Dimopoulos, Chor Sang Chim, Rik Schots, A Noeul, Dorotea Fantl, U-H Mellqvist, Ola Landgren, Asher Chanan‐Khan, Philippe Moreau, Rafaël Fonseca, Giampaolo Merlini, Juan José Lahuerta, Joan Bladé, Robert Z. Orlowski, Jatin J. Shah (2012). Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group. , 27(4), DOI: https://doi.org/10.1038/leu.2012.336.
Article36 days ago